UMass Chan cancer biologist receives New Innovator Award for developing DNA sequencing technology
William Flavahan, PhD, is one of 40 recipients of the $1.5 million NIH Director’s New Innovator Award, designed to support early career investigators who are proposing bold research.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Award, Research, Molecular, Cell and Cancer Biology, Latest News, William Flavahan,
Recent Publications
Banday et al. The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Nat Commun, 2025. Article | Green Lab
Whalen et al. Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability. Nat Cancer, 2025. Article | Cantor Lab
Ou et al. InPAS: An R/Bioconductor package for identifying novel polyadenylation sites and alternative polyadenylation from bulk RNA-seq data. Front Biosci, 2024. Article | Bioinformatics Core